A privately held drug delivery technology company.
Researching the development of proprietary Vasoactive Intestinal Peptide (VIP) drug.
Developing novel heart valve replacement technology.
Technical consulting services offering strategic planning, product development, systems engineering , and program management services
a clinical-stage company dedicated to developing novel, bioactive peptides that prevent injury progression and thereby rescue tissue and speed healing.
Developers of groundbreaking advanced materials and manufacturing platforms.
Providing integrated R&D support in all the key areas of pre-clinical research.
iCell Gene Therapeutics is focused on creating novel immunotherapies for cancer treatment through the development of Chimeric Antigen Receptor (CAR) therapies that target and destroy multiple types of cancer.
Hand Surgery Resource is developing an online text and training tools for hand surgeons, students and support staff.
Developing patented biotechnology related to the generation of immune cells from stem cells within the body to treat immunodeficiency.